Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Temple

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|February 21, 1975
Letters to the editorR J Temple
British Journal of Clinical Pharmacology|July 1, 1996
The clinical pharmacologist in drug regulation: the US perspectiveR J Temple
Controlled Clinical Trials|December 31, 1997
When are clinical trials of a given agent vs. placebo no longer appropriate or feasible?R J Temple
Annals of the New York Academy of Sciences|January 1, 1981
The effect of the Drug Regulation Reform Act of 1978 on clinical research, drug availability, and the public healthR J Temple
Annals of the New York Academy of Sciences|January 1, 1981
New drug development in the changing health care environment: a panel discussionA Flanagan, R J Temple, W M Wardell
Clinical Pharmacology and Therapeutics|August 1, 1989
Understanding comparisons of drug introductions between the United States and the United KingdomP L Coppinger, C C Peck, R J Temple
The New England Journal of Medicine|May 3, 1979
Adverse effects of newly marketed drugsR J Temple, J K Jones, J R Crout
The New England Journal of Medicine|November 17, 1994
Therapeutic-class wars--drug promotion in a competitive marketplaceD A Kessler, J L Rose, R J Temple, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Response to Monro and Mehta proposal for use of single-dose toxicology studies to support single-dose studies of new drugs in humansJ Choudary, J F Contrera, A DeFelice, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|February 21, 1975
Letters to the editorR J Temple
British Journal of Clinical Pharmacology|July 1, 1996
The clinical pharmacologist in drug regulation: the US perspectiveR J Temple
Controlled Clinical Trials|December 31, 1997
When are clinical trials of a given agent vs. placebo no longer appropriate or feasible?R J Temple
Annals of the New York Academy of Sciences|January 1, 1981
The effect of the Drug Regulation Reform Act of 1978 on clinical research, drug availability, and the public healthR J Temple
Annals of the New York Academy of Sciences|January 1, 1981
New drug development in the changing health care environment: a panel discussionA Flanagan, R J Temple, W M Wardell
Clinical Pharmacology and Therapeutics|August 1, 1989
Understanding comparisons of drug introductions between the United States and the United KingdomP L Coppinger, C C Peck, R J Temple
The New England Journal of Medicine|May 3, 1979
Adverse effects of newly marketed drugsR J Temple, J K Jones, J R Crout
The New England Journal of Medicine|November 17, 1994
Therapeutic-class wars--drug promotion in a competitive marketplaceD A Kessler, J L Rose, R J Temple, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Response to Monro and Mehta proposal for use of single-dose toxicology studies to support single-dose studies of new drugs in humansJ Choudary, J F Contrera, A DeFelice, et al.
Pageof 1